RAD51-IN-2 free base · Synonyms: Emzadirib | CYT-0851

Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1 .

For research use only. Not for human or veterinary use.

Target RAD51

Research area Cancer

Purity >98% Stock Inquire

Data Sheet SDS COA

RAD51-IN-2 structure

CAS No.: 2301085-04-9

Pack sizes & pricing

Size	Price	SKU	Stock
25 mg	USD 1,150.00	BP-01217-25mg	In stock	Get quote
50 mg	USD 1,850.00	BP-01217-50mg	In stock	Get quote
100 mg	USD 2,549.00	BP-01217-100mg	In stock	Get quote
250 mg	USD 3,985.00	BP-01217-250mg	In stock	Get quote
500 mg	Inquire	BP-01217-500mg	In stock	Inquire

Need another size or custom synthesis? Request a quote.

Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1 .

In Vitro Emzadirib exhibts an EC50 of ≤1 μM in activation-induced cytidine deaminase (AID) positive cells.

SMILES: CC(OC(N[C@H]1CC[C@H](C2=NC=C(C3=CC=C(NC(OC(C)C)=O)C=C3S(=O)(NC(C)(C)C)=O)S2)CC1)=O)C
InChIKey: OVXFEICGTUUFPE-WGSAOQKQSA-N

MW (average): 580.7600
Formula: C₂₇H₄₀N₄O₆S₂
CAS No.: 2301085-04-9
Physical state: Solid
Color: white to off-white
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder 4℃ 2 years; In solvent -20℃ 1 month;

soluble in DMSO

[1]. Alfredo C. Castro, et al. Rad51 inhibitors. WO2019/051465A1.

Search Cancer